A year after receiving approval by the Food and Drug Administration, the new weight-loss drug Belviq is finally available by prescription. But you may not want to rush out and get it. It's only approved for people who are obese, with a ...
Pfizer has reached a $2.15bn settlement with Teva Pharmaceuticals Industries, and Sun Pharmaceutical Industries over Protonix patent-infringement lawsuit in the US. Following 10-years of litigation over the intellectual property for ...
Tags: Pfizer, Sun Pharma
The European Medicines Agency has cleared Roche's RoACTEMRA for the treatment of a rare form of arthritis, polyarticular juvenile idiopathic arthritis (PJIA), in children aged two years and above. Approved for use alone or in combination ...
Tags: Arthritis Drug, Medicine
Takeda Pharmaceutical Company, AMAG Pharmaceuticals' European commercial partner, has submitted a type-II variation to the European Medicines Agency (EMA) for label expansion of Rienso (ferumoxytol). The approval will allow the use of ...
Tags: Takeda, EMA Approval
AstraZeneca Neuroscience Innovative Medicines (AZ NS iMed) has partnered with clinical services and eClinical solutions provider ePharmaSolutions to optimize clinical trial management technology. iMed will leverage IT solutions to share ...
US-based inhaled medicines provider Genoa Pharmaceuticals in collaboration with McMaster University has demonstrated advantages of the inhaled aerosol pirfenidone (GP-101) in the treatment of pulmonary fibrosis. The findings showed that ...
Tags: Genoa, Mcmaster University
In May, the consumer price index (CPI) went up by 2.1 percent year-on-year. The prices grew by 2.1 percent in cities and 2.2 percent in rural areas. The food prices went up by 3.2 percent, while the non-food prices increased by 1.6 percent. ...
Tags: economy, Consumer Prices, china
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Celgene International's oral anti-cancer therapy Pomalidomide. The positive results from the MM-003 study of ...
Astellas Pharma and Medivation have announced the Health Canada approval of Xtandi (enzalutamide) capsules to treat metastatic castration-resistant prostate cancer. The oral, once-daily androgen receptor inhibitor is indicated for ...
Tags: Astellas Pharma, Medicine
The European Union (EU) is expected to penalize nine companies, including Denmark-based Lundbeck and Indian firm Ranbaxy for halting generic medicines from entering into the market and violating competition laws. Other companies scheduled ...
Tags: Drug Firms, Drugs'Entry
Pfizer has collaborated with the University of California, San Francisco (UCSF) to expand its centers for therapeutic innovation (CTI) into the development of small-molecule drug candidates and enhance its drug discovery capabilities. ...
The AidPod for ColaLife has all the right components to become the packaging system that definitively demonstrates to the world that packaging can not only add value to consumers' lives, but it can actually save lives. Recently garnering ...
From January to April, the industrial profits of enterprises above designated size achieved 1,610.69 billion yuan, an increase of 11.4 percent over the same period last year, and down by 0.7 percentage point over the first three months. In ...
Tags: Industrial Profits, China
Johnson & Johnson's Pharmaceuticals unit Janssen is planning to submit more than 10 new products for regulatory approval and extend the brand pipeline of 25 existing drugs by 2017. The late stage products to be submitted for approval ...
Tags: Johnson&Johnson, New Drugs
Tokyo-based Astellas Pharma’s European subsidiary has announced that it has received marketing authorization from the Netherlands Medicines Evaluation Board (MEB) for Vesomni. The marketing authorization received for Vesomni is ...
Tags: Netherlands Meb, Medicine